Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE8B | O95263 | 1/20 | 0.46 |
| ▸ | KDM1A | O60341 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.37 |
| ▸ | PREP | P48147 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11990570 | 0.86 | PDE8B (0.47) | PDE8BKDM1AATMHSD17B10HPGD | |
| SCHEMBL11995153 | 0.86 | PDE8B (0.47) | PDE8BKDM1AATMHSD17B10HPGD | |
| SCHEMBL4400837 | 0.86 | PDE8B (0.47) | PDE8BKDM1AATMHSD17B10HPGD | |
| SCHEMBL25867303 | 0.84 | PDE8B (0.47) | PDE8BKDM1AATMHSD17B10HPGD | |
| SCHEMBL7203146 | 0.83 | PDE8B (0.46) | PDE8BKDM1AATMHSD17B10HPGD | |
| SCHEMBL28196934 | 0.81 | HSD17B10 (0.46) | PDE8BATMHSD17B10SMN1; SMN2ALDH1A1 | |
| SCHEMBL1516388 | 0.81 | HSD17B10 (0.46) | PDE8BATMHSD17B10SMN1; SMN2ALDH1A1 | |
| SCHEMBL115847 | 0.81 | HSD17B10 (0.46) | PDE8BATMHSD17B10SMN1; SMN2ALDH1A1 | |
| SCHEMBL192841 | 0.81 | POLB (0.51) | PDE8BKDM1AATMHSD17B10HPGD | |
| SCHEMBL282976 | 0.81 | POLB (0.51) | PDE8BKDM1AATMHSD17B10HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1399160-A4 | NR2B RECEPTOR ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF MIGRAINES | MERCK & CO INC (US) | 2004-08-25 | — | — | EP | disclosed |
| EP-1399160-A2 | NR2B RECEPTOR ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF MIGRAINES | Merck & Co., Inc. (US) | 2004-03-24 | — | — | EP | disclosed |
| WO-2002100352-A2 | NR2B RECEPTOR ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF MIGRAINES | MERCK & CO., INC. (US) | 2002-12-19 | — | — | WO | disclosed |